Objective: To estimate the incremental cost-effectiveness ratio of a structured community pharmacist-based smoking cessation programme compared with usual care.
Design: A cost-effectiveness study using a healthcare system perspective
Population: Two simulated cohorts of smokers: male and female aged 40, 50 and 60 years who regularly smoke 10–20 cigarettes per day.
Intervention and comparator: A structured community pharmacist-based smoking cessation (CPSC) programme compared to usual care.
Main outcome measure: Cost per life year gained (LYG) attributable to the smoking cessation programme.
Results: The CPSC programme results in cost savings of 17 503.53 baht (£250; €325; $500) to the health system and life year gains of 0.18 years for men and; costs savings of 21 499.75 baht (£307; €399; $614) and life year gains of 0.24 years for women. A series of sensitivity analyses demonstrate that both cost savings and life year gains are sensitive to variations in the discount rate and the long-term smoking quit rate associated with the intervention.
Conclusion: From the perspective of the health system, the CPSC programme yields cost savings and life year gains. This finding provides important information for health policy decision-makers when determining the magnitude of resources to be allocated to smoking cessation service in community pharmacy.
Statistics from Altmetric.com
Funding: This study was supported, in part, by a grant from the Thailand Research Fund and Thai Pharmacy Network for Tobacco Control (through the Thai Health Promotion Foundation).
Competing interests: None.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.